Frederic Mack
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
-
- Brain Metastases and Treatment
Papers in
- Genetics 17
- Glioma Diagnosis and Treatment 17
-
- Medical Imaging Techniques and Applications 2
- Co-authors
- Ulrich Herrlinger (13 shared papers)Martin Glas (13 shared papers)Björn Scheffler (8 shared papers)Niklas Schäfer (11 shared papers)Moritz Stuplich (9 shared papers)Sied Kebir (10 shared papers)Matthias Simon (7 shared papers)Christina Schaub (9 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Neuro-Oncology (3 papers)Oncology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Journal of Neuro-Oncology (2 papers)
- Partner nations
- Germany
In The Last Decade
Frederic Mack
20 papers receiving 1.1k citations
Frederic Mack's Hit Papers
Peers
Comparison fields: 5 of 61
- Genetics 781
- Pulmonary and Respiratory Medicine 162
- Radiology, Nuclear Medicine and Imaging 104
- Oncology 87
- Cancer Research 30
Countries citing papers authored by Frederic Mack
This map shows the geographic impact of Frederic Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Mack more than expected).
Fields of papers citing papers by Frederic Mack
This network shows the impact of papers produced by Frederic Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Mack. The network helps show where Frederic Mack may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederic Mack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 439 |
| 2 | 2016 | 160 | |
| 3 | 2015 | 126 | |
| 4 | 2015 | 106 | |
| 5 | 2012 | 49 | |
| 6 | 2013 | 43 | |
| 7 | 2019 | 41 | |
| 8 | 2016 | 31 | |
| 9 | 2016 | 23 | |
| 10 | 2013 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2011 | 15 | |
| 13 | 2014 | 15 | |
| 14 | 2016 | 14 | |
| 15 | 2017 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2012 | 9 | |
| 19 | 2014 | 6 | |
| 20 | 2019 | 1 |
About Frederic Mack
Frederic Mack is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging, Neurology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Medical Imaging Techniques and Applications (2 papers), Multiple Sclerosis Research Studies (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper), Melanoma and MAPK Pathways (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Genetics (781 citations), Pulmonary and Respiratory Medicine (162 citations), Radiology, Nuclear Medicine and Imaging (104 citations), Oncology (87 citations) and Cancer Research (30 citations). Frederic Mack has collaborated with scholars based in Germany. Frequent co-authors include Ulrich Herrlinger, Martin Glas, Björn Scheffler, Niklas Schäfer, Moritz Stuplich, Sied Kebir, Matthias Simon, Christina Schaub, Nico Schäfer and Elke Hattingen. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Oncology, Journal of Cancer Research and Clinical Oncology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.